A Phase Ia/Ib Clinical Trial of PRI-724 in Patients With Advanced Solid Tumors

Trial Profile

A Phase Ia/Ib Clinical Trial of PRI-724 in Patients With Advanced Solid Tumors

Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2015

At a glance

  • Drugs PRI 724 (Primary)
  • Indications Colorectal cancer; Pancreatic cancer; Solid tumours
  • Focus Adverse reactions
  • Sponsors PRISM Pharma Co
  • Most Recent Events

    • 05 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Jun 2015, as reported by ClinicalTrials.gov record.
    • 05 Jun 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov record.
    • 29 Oct 2014 Planned End Date changed from 1 May 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top